HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: M300120-JLR200v1 44/8/1441    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Granlund, L. Articles by Nebb, H. I. Search for Related Content PubMed PubMed Citation Articles by Granlund, L. Articles by Nebb, H. I. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol. 44, 1441-1452, August 2003
Copyright © 2003 by American Society for Biochemistry and Molecular Biology

Trans10, cis12-conjugated linoleic acid prevents triacylglycerol accumulation in adipocytes by acting as a PPAR modulator

Linda Granlund, Lene K. Juvet, Jan I. Pedersen and Hilde I. Nebb¹

Institute for Nutrition Research, University of Oslo, N-0316 Oslo, Norway

¹ To whom correspondence should be addressed. e-mail: h.i.nebb{at}basalmed.uio.no

A group of polyunsaturated fatty acids called conjugated linoleic acids (CLAs) are found in ruminant products, where the most common isomers are cis9, trans11 (c 9,t11) and trans10, cis12 (t10,c12) CLA. A crude mixture of these isomers has been shown in animal studies to alter body composition by a reduction in body fat mass as well as an increase in lean body mass, with the t10,c12 isomer having the most pronounced effect. The objective of this study was to establish the molecular mechanisms by which t10,c12 CLA affects lipid accumulation in adipocytes. We have shown that t10,c12 CLA prevents lipid accumulation in human and mouse adipocytes at concentrations as low as 5 µM and 25 µM, respectively. t10,c12 CLA fails to activate peroxisome proliferator-activated receptor (PPAR) but selectively inhibits thiazolidinedione-induced PPAR activation in 3T3-L1 adipocytes. Treatment of mature adipocytes with t10,c12 CLA alone or in combination with Darglitazone down-regulates the mRNA expression of PPAR as well as its target genes, fatty acid binding protein (aP2) and liver X receptor (LXR).

Taken together, our results suggest that the trans10, cis12 CLA isomer prevents lipid accumulation in adipocytes by acting as a PPAR modulator.

Abbreviations: aP2, fatty acid binding protein (also known as aFABP); CLA, conjugated linoleic acid; LXR, liver X receptor; PPAR, peroxisome proliferator-activated receptor; RXR, retinoid X receptor; SGBS, Simpson-Golabi-Behmel syndrome; TAG, triacylglycerol, TZD, thiazolidinediones

Supplementary key words fatty acid binding protein • liver X receptor • Darglitazone

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. R. Miller, P. Siripurkpong, J. Hawes, A. Majdalawieh, H.-S. Ro, and R. S. McLeod The trans-10, cis-12 isomer of conjugated linoleic acid decreases adiponectin assembly by PPAR{gamma}-dependent and PPAR{gamma}-independent mechanisms J. Lipid Res., March 1, 2008; 49(3): 550 - 562. [Abstract] [Full Text] [PDF]

				A. Kennedy, S. Chung, K. LaPoint, O. Fabiyi, and M. K. McIntosh Trans-10, Cis-12 Conjugated Linoleic Acid Antagonizes Ligand-Dependent PPAR{gamma} Activity in Primary Cultures of Human Adipocytes J. Nutr., March 1, 2008; 138(3): 455 - 461. [Abstract] [Full Text] [PDF]

				A. A. Spector and A. W. Norris Action of epoxyeicosatrienoic acids on cellular function Am J Physiol Cell Physiol, March 1, 2007; 292(3): C996 - C1012. [Abstract] [Full Text] [PDF]

				J. S.W. Taylor, S. R.P. Williams, R. Rhys, P. James, and M. P. Frenneaux Conjugated Linoleic Acid Impairs Endothelial Function Arterioscler. Thromb. Vasc. Biol., February 1, 2006; 26(2): 307 - 312. [Abstract] [Full Text] [PDF]

				R. L. House, J. P. Cassady, E. J. Eisen, T. E. Eling, J. B. Collins, S. F. Grissom, and J. Odle Functional genomic characterization of delipidation elicited by trans-10, cis-12-conjugated linoleic acid (t10c12-CLA) in a polygenic obese line of mice Physiol Genomics, May 11, 2005; 21(3): 351 - 361. [Abstract] [Full Text] [PDF]

				L. A. Sauer, R. T. Dauchy, D. E. Blask, J. A. Krause, L. K. Davidson, E. M. Dauchy, K. J. Welham, and K. Coupland Conjugated Linoleic Acid Isomers and Trans Fatty Acids Inhibit Fatty Acid Transport in Hepatoma 7288CTC and Inguinal Fat Pads in Buffalo Rats J. Nutr., August 1, 2004; 134(8): 1989 - 1997. [Abstract] [Full Text] [PDF]

				J.-M. Gaullier, J. Halse, K. Hoye, K. Kristiansen, H. Fagertun, H. Vik, and O. Gudmundsen Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans Am. J. Clinical Nutrition, June 1, 2004; 79(6): 1118 - 1125. [Abstract] [Full Text] [PDF]

				C. G Taylor and P. Zahradka Dietary conjugated linoleic acid and insulin sensitivity and resistance in rodent models Am. J. Clinical Nutrition, June 1, 2004; 79(6): 1164S - 1168S. [Abstract] [Full Text] [PDF]

				T. M. Larsen, S. Toubro, and A. Astrup Efficacy and safety of dietary supplements containing CLA for the treatment of obesity: evidence from animal and human studies J. Lipid Res., December 1, 2003; 44(12): 2234 - 2241. [Abstract] [Full Text] [PDF]

				J. M. Brown and M. K. McIntosh Conjugated Linoleic Acid in Humans: Regulation of Adiposity and Insulin Sensitivity J. Nutr., October 1, 2003; 133(10): 3041 - 3046. [Abstract] [Full Text] [PDF]